Application of Near Infrared Spectroscopy, Intravascular Ultrasound and the Coronary Calcium Score to Predict Adverse Coronary Events
Abstract
A total of 1126 patients were screened for inclusion in the trial. A total of 55 patients were enrolled and completed initial invasive evaluation. The last of these was enrolled on September 22, 2016. The initial trial design calls for 5 year follow-up to adjudicate clinical events. A request to continue patient follow-up to 5 years by extending the study was not granted. Five year follow-up for the first patient enrolled (6/9/14) will occur in 2019. Interim events have occurred to date in only 9 patients with only one death. No relationship to any study variable can be made with such a low event rate on preliminary follow-up date. Funding for continued data collection for all enrolled patients to the 5 year end point is being sought locally.
Document Details
- Document Type
- Technical Report
- Publication Date
- Dec 01, 2016
- Accession Number
- AD1057808
Entities
People
- Charles Lambert